Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH

Serum levels of fibroblast growth factor 23 (FGF23) markedly increase with renal impairment, with FGF23 levels correlating with the presence of left ventricular hypertrophy (LVH) and mortality in patients with chronic kidney disease (CKD). FGF23 activates calcineurin/nuclear factor of activated T ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinology
Main Authors: Liu, Eva S, Thoonen, Robrecht, Petit, Elizabeth, Yu, Binglan, Buys, Emmanuel S, Scherrer-Crosbie, Marielle, Demay, Marie B
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915960/
https://ncbi.nlm.nih.gov/pubmed/29635291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2018-00174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados